| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3988048 | European Journal of Surgical Oncology (EJSO) | 2006 | 4 Pages |
Abstract
This study shows that G17DT administered to jaundiced patients with advanced pancreatic cancer is immunogenic and well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.S. Takhar, A.D. Gilliam, S.A. Watson, M. Henwood, B.J. Rowlands, P. Broome, I.J. Beckingham,